Healthcare at Home seeks development capital
publication date: Jun 29, 2011
Healthcare at Home (HAH), the international homecare business with sales of £814m in 2010, has appointed bankers UBS to raise more funds to refinance the business and provide development capital to expand. There are rumours that Hutton Collins, the private equity house, which has a minority stake in HAH, wants to sell, but HAH head of marketing Steve Davis says: "we believe their preference is to continue to hold a stake in the business going forwards." We profile HAH and put it into the context of the broader European homecare market.
To get full access to this article you will need to subscribe to Healthcare Europa. This gives you indepth quality coverage of how the dynamic private healthcare sector is developing across Europe.
Please click here to look at subscription options.
You can, however, register for free to recieve limited access. This gives you access to headlines and the first lines of stories and you can ask us to send you a news email with headlines 40 times a year. As a free registrant, you can also view our blog. Click here to sign up for limited access free registration.
